Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator Grant from Innosuisse to Develop Antibody-Drug Conjugate Candidates
Innosuisse supports 53 companies out of 752 applications with total CHF 112M Araris’ awarded grant will be used to support...
Read moreDetails